Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer (Q88911056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Benedicte F Jordan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

1 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

671-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

Body Fatness and Cancer--Viewpoint of the IARC Working Group.

29 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Global burden of cancer attributable to high body-mass index in 2012: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

At the crossroads of inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

1 reference

7 January 2021

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Epidemiologic studies of the human microbiome and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The role of the microbiota in inflammation, carcinogenesis, and cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The microbiome modulates the tumor macroenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The microbiome and cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The microbiome and the hallmarks of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

An integrated catalog of reference genes in the human gut microbiome

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Towards a more comprehensive concept for prebiotics

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Emergence of microbial diversity due to cross-feeding interactions in a spatial model of gut microbial metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Some are more equal than others: the role of "keystone" species in the degradation of recalcitrant substrates

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Formation of propionate and butyrate by the human colonic microbiota

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut cell metabolism shapes the microbiome

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

GPCR-Mediated Signaling of Metabolites

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The effect of gut microbiota on drug metabolism

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Is It Time for a Metagenomic Basis of Therapeutics?

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Chemical transformation of xenobiotics by the human gut microbiota.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Crosstalk between the microbiome and epigenome: messages from bugs.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

MicroRNAs and bacterial infection.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

How gut microbes talk to organs: The role of endocrine and nervous routes

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbiota, enteroendocrine functions and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbiota and GLP-1.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Microbial modulation of energy availability in the colon regulates intestinal transit

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Effect of the GLP-1 analog exendin-4 and oxaliplatin on intrahepatic cholangiocarcinoma cell line and mouse model

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Exenatide modulates tumor-endothelial cell interactions in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Adipose Tissue Metabolism and Cancer Progression: Novel Insights from Gut Microbiota?

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Obesity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Metabolic endotoxemia and diabetes mellitus: A systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Molecular Pathways Linking Inflammation and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Chylomicrons promote intestinal absorption of lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Energy intake is associated with endotoxemia in apparently healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Endotoxemia is associated with an increased risk of incident diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Homeostasis of the gut barrier and potential biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Mucin-bacterial interactions in the human oral cavity and digestive tract

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Innate immune signalling at the intestinal epithelium in homeostasis and disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Immune adaptations that maintain homeostasis with the intestinal microbiota

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The habitat, double life, citizenship, and forgetfulness of IgA.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Enterocyte death and intestinal barrier maintenance in homeostasis and disease

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Intectin, a novel small intestine-specific glycosylphosphatidylinositol-anchored protein, accelerates apoptosis of intestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The endocannabinoid system links gut microbiota to adipogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Antigen sampling in the small intestine

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Regulation of obesity-related insulin resistance with gut anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Common flora and intestine: A carcinogenic marriage

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The dichotomy of T helper 17 cells in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The dichotomous nature of T helper 17 cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Radical causes of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Reactive oxygen species in inflammation and tissue injury

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Insights into the role of the intestinal microbiota in colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The Yin and Yang of Toll-like receptors in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Upregulation of TLRs and IL-6 as a marker in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Pathogen recognition receptors, cancer and inflammation in the gut.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC(Min/+) mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Colorectal cancer in mice genetically deficient in the mucin Muc2

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Dysplasia and Cancer in Inflammatory Bowel Disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Lipopolysaccharide promotes tumorigenicity of hepatic progenitor cells by promoting proliferation and blocking normal differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Periodontal Pathogens in the Etiology of Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Towards the human colorectal cancer microbiome

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The gut microbiome and liver cancer: mechanisms and clinical translation.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Insights into the role of the microbiome in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

A metagenome-wide association study of gut microbiota in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Diet, microorganisms and their metabolites, and colon cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

GPR109a: the missing link between microbiome and good health?

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The gut microbiome modulates colon tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Normalization of obesity-associated insulin resistance through immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Metabolic control of regulatory T cell development and function

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Non-alcoholic steatohepatitis: a microbiota-driven disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbiome and liver diseases.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The gut microbiota and host health: a new clinical frontier

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Epiregulin promotes the emergence and proliferation of adult liver progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Microbial ecology: human gut microbes associated with obesity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Interaction of gut microbiota with bile acid metabolism and its influence on disease states

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Dietary microbes modulate transgenerational cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Periodontal inflammation and insulin resistance--lessons from obesity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

A proposed model linking inflammation to obesity, diabetes, and periodontal infections

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Increased oral inflammation, leukocytes, and leptin, and lower adiponectin in overweight or obesity.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Oxidative Stress and Periodontal Disease in Obesity

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

State of the science: chronic periodontitis and systemic health

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

An exploration of the periodontitis-cancer association.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Tooth loss, pancreatic cancer, and Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Microbiota, oral microbiome, and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Porphyromonas gingivalis downregulates the immune response of fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Characterization of the salivary microbiome in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor.

1 reference

https://api.crossref.org/works/10.1038%2FS41575-018-0025-6

7 January 2021

10.1038/S41575-018-0025-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29844585%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference